Global Embolization Particle Market Insights and Forecast to 2028

Report ID: 1123235 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Embolization Particle Product Introduction
    1.2 Market by Type
        1.2.1 Global Embolization Particle Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Microspheres
        1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
        1.2.4 Drug-eluting Beads (DEBs)
        1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
    1.3 Market by Application
        1.3.1 Global Embolization Particle Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Uterine Fibroid Embolization
        1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
        1.3.4 Liver Tumor Embolization
        1.3.5 Trauma Embolization
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Embolization Particle Sales Estimates and Forecasts 2017-2028
    2.2 Global Embolization Particle Revenue Estimates and Forecasts 2017-2028
    2.3 Global Embolization Particle Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Embolization Particle Sales by Region
        2.4.1 Global Embolization Particle Sales by Region (2017-2022)
        2.4.2 Global Sales Embolization Particle by Region (2023-2028)
    2.5 Global Embolization Particle Revenue by Region
        2.5.1 Global Embolization Particle Revenue by Region (2017-2022)
        2.5.2 Global Embolization Particle Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Embolization Particle Sales by Manufacturers
        3.1.1 Global Top Embolization Particle Manufacturers by Sales (2017-2022)
        3.1.2 Global Embolization Particle Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Embolization Particle in 2021
    3.2 Global Embolization Particle Revenue by Manufacturers
        3.2.1 Global Embolization Particle Revenue by Manufacturers (2017-2022)
        3.2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Embolization Particle Revenue in 2021
    3.3 Global Embolization Particle Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Embolization Particle Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Embolization Particle Sales by Type
        4.1.1 Global Embolization Particle Historical Sales by Type (2017-2022)
        4.1.2 Global Embolization Particle Forecasted Sales by Type (2023-2028)
        4.1.3 Global Embolization Particle Sales Market Share by Type (2017-2028)
    4.2 Global Embolization Particle Revenue by Type
        4.2.1 Global Embolization Particle Historical Revenue by Type (2017-2022)
        4.2.2 Global Embolization Particle Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Embolization Particle Revenue Market Share by Type (2017-2028)
    4.3 Global Embolization Particle Price by Type
        4.3.1 Global Embolization Particle Price by Type (2017-2022)
        4.3.2 Global Embolization Particle Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Embolization Particle Sales by Application
        5.1.1 Global Embolization Particle Historical Sales by Application (2017-2022)
        5.1.2 Global Embolization Particle Forecasted Sales by Application (2023-2028)
        5.1.3 Global Embolization Particle Sales Market Share by Application (2017-2028)
    5.2 Global Embolization Particle Revenue by Application
        5.2.1 Global Embolization Particle Historical Revenue by Application (2017-2022)
        5.2.2 Global Embolization Particle Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Embolization Particle Revenue Market Share by Application (2017-2028)
    5.3 Global Embolization Particle Price by Application
        5.3.1 Global Embolization Particle Price by Application (2017-2022)
        5.3.2 Global Embolization Particle Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Embolization Particle Market Size by Type
        6.1.1 North America Embolization Particle Sales by Type (2017-2028)
        6.1.2 North America Embolization Particle Revenue by Type (2017-2028)
    6.2 North America Embolization Particle Market Size by Application
        6.2.1 North America Embolization Particle Sales by Application (2017-2028)
        6.2.2 North America Embolization Particle Revenue by Application (2017-2028)
    6.3 North America Embolization Particle Market Size by Country
        6.3.1 North America Embolization Particle Sales by Country (2017-2028)
        6.3.2 North America Embolization Particle Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Embolization Particle Market Size by Type
        7.1.1 Europe Embolization Particle Sales by Type (2017-2028)
        7.1.2 Europe Embolization Particle Revenue by Type (2017-2028)
    7.2 Europe Embolization Particle Market Size by Application
        7.2.1 Europe Embolization Particle Sales by Application (2017-2028)
        7.2.2 Europe Embolization Particle Revenue by Application (2017-2028)
    7.3 Europe Embolization Particle Market Size by Country
        7.3.1 Europe Embolization Particle Sales by Country (2017-2028)
        7.3.2 Europe Embolization Particle Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Embolization Particle Market Size by Type
        8.1.1 Asia Pacific Embolization Particle Sales by Type (2017-2028)
        8.1.2 Asia Pacific Embolization Particle Revenue by Type (2017-2028)
    8.2 Asia Pacific Embolization Particle Market Size by Application
        8.2.1 Asia Pacific Embolization Particle Sales by Application (2017-2028)
        8.2.2 Asia Pacific Embolization Particle Revenue by Application (2017-2028)
    8.3 Asia Pacific Embolization Particle Market Size by Region
        8.3.1 Asia Pacific Embolization Particle Sales by Region (2017-2028)
        8.3.2 Asia Pacific Embolization Particle Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Embolization Particle Market Size by Type
        9.1.1 Latin America Embolization Particle Sales by Type (2017-2028)
        9.1.2 Latin America Embolization Particle Revenue by Type (2017-2028)
    9.2 Latin America Embolization Particle Market Size by Application
        9.2.1 Latin America Embolization Particle Sales by Application (2017-2028)
        9.2.2 Latin America Embolization Particle Revenue by Application (2017-2028)
    9.3 Latin America Embolization Particle Market Size by Country
        9.3.1 Latin America Embolization Particle Sales by Country (2017-2028)
        9.3.2 Latin America Embolization Particle Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Embolization Particle Market Size by Type
        10.1.1 Middle East and Africa Embolization Particle Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Embolization Particle Revenue by Type (2017-2028)
    10.2 Middle East and Africa Embolization Particle Market Size by Application
        10.2.1 Middle East and Africa Embolization Particle Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Embolization Particle Revenue by Application (2017-2028)
    10.3 Middle East and Africa Embolization Particle Market Size by Country
        10.3.1 Middle East and Africa Embolization Particle Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Embolization Particle Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sirtex Medical
        11.1.1 Sirtex Medical Corporation Information
        11.1.2 Sirtex Medical Overview
        11.1.3 Sirtex Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sirtex Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sirtex Medical Recent Developments
    11.2 Merit Medical
        11.2.1 Merit Medical Corporation Information
        11.2.2 Merit Medical Overview
        11.2.3 Merit Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merit Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merit Medical Recent Developments
    11.3 Cook Medical
        11.3.1 Cook Medical Corporation Information
        11.3.2 Cook Medical Overview
        11.3.3 Cook Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Cook Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Cook Medical Recent Developments
    11.4 BTG Medical
        11.4.1 BTG Medical Corporation Information
        11.4.2 BTG Medical Overview
        11.4.3 BTG Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 BTG Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 BTG Medical Recent Developments
    11.5 Boston Scientific Corporation
        11.5.1 Boston Scientific Corporation Corporation Information
        11.5.2 Boston Scientific Corporation Overview
        11.5.3 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Boston Scientific Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Boston Scientific Corporation Recent Developments
    11.6 Terumo Corporation
        11.6.1 Terumo Corporation Corporation Information
        11.6.2 Terumo Corporation Overview
        11.6.3 Terumo Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Terumo Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Terumo Corporation Recent Developments
    11.7 HENGRUI Medical
        11.7.1 HENGRUI Medical Corporation Information
        11.7.2 HENGRUI Medical Overview
        11.7.3 HENGRUI Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 HENGRUI Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 HENGRUI Medical Recent Developments
    11.8 INterface BIOmaterials B.V.
        11.8.1 INterface BIOmaterials B.V. Corporation Information
        11.8.2 INterface BIOmaterials B.V. Overview
        11.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 INterface BIOmaterials B.V. Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 INterface BIOmaterials B.V. Recent Developments
    11.9 Alicon
        11.9.1 Alicon Corporation Information
        11.9.2 Alicon Overview
        11.9.3 Alicon Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Alicon Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Alicon Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Embolization Particle Industry Chain Analysis
    12.2 Embolization Particle Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Embolization Particle Production Mode & Process
    12.4 Embolization Particle Sales and Marketing
        12.4.1 Embolization Particle Sales Channels
        12.4.2 Embolization Particle Distributors
    12.5 Embolization Particle Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Embolization Particle Industry Trends
    13.2 Embolization Particle Market Drivers
    13.3 Embolization Particle Market Challenges
    13.4 Embolization Particle Market Restraints
14 Key Findings in The Global Embolization Particle Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Embolization Particle Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Microspheres
    Table 3. Major Manufacturers of Particles (e.g. PVA Particles, Gelfoam Particles)
    Table 4. Major Manufacturers of Drug-eluting Beads (DEBs)
    Table 5. Major Manufacturers of Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
    Table 6. Global Embolization Particle Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Embolization Particle Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Embolization Particle Sales by Region (2017-2022) & (K Units)
    Table 9. Global Embolization Particle Sales Market Share by Region (2017-2022)
    Table 10. Global Embolization Particle Sales by Region (2023-2028) & (K Units)
    Table 11. Global Embolization Particle Sales Market Share by Region (2023-2028)
    Table 12. Global Embolization Particle Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Embolization Particle Revenue Market Share by Region (2017-2022)
    Table 14. Global Embolization Particle Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Embolization Particle Revenue Market Share by Region (2023-2028)
    Table 16. Global Embolization Particle Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Embolization Particle Sales Share by Manufacturers (2017-2022)
    Table 18. Global Embolization Particle Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Embolization Particle Revenue Share by Manufacturers (2017-2022)
    Table 20. Embolization Particle Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Embolization Particle Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Embolization Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization Particle as of 2021)
    Table 23. Embolization Particle Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Embolization Particle Product Offered
    Table 25. Date of Manufacturers Enter into Embolization Particle Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Embolization Particle Sales by Type (2017-2022) & (K Units)
    Table 28. Global Embolization Particle Sales by Type (2023-2028) & (K Units)
    Table 29. Global Embolization Particle Sales Share by Type (2017-2022)
    Table 30. Global Embolization Particle Sales Share by Type (2023-2028)
    Table 31. Global Embolization Particle Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Embolization Particle Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Embolization Particle Revenue Share by Type (2017-2022)
    Table 34. Global Embolization Particle Revenue Share by Type (2023-2028)
    Table 35. Embolization Particle Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Embolization Particle Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Embolization Particle Sales by Application (2017-2022) & (K Units)
    Table 38. Global Embolization Particle Sales by Application (2023-2028) & (K Units)
    Table 39. Global Embolization Particle Sales Share by Application (2017-2022)
    Table 40. Global Embolization Particle Sales Share by Application (2023-2028)
    Table 41. Global Embolization Particle Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Embolization Particle Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Embolization Particle Revenue Share by Application (2017-2022)
    Table 44. Global Embolization Particle Revenue Share by Application (2023-2028)
    Table 45. Embolization Particle Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Embolization Particle Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Embolization Particle Sales by Type (2017-2022) & (K Units)
    Table 48. North America Embolization Particle Sales by Type (2023-2028) & (K Units)
    Table 49. North America Embolization Particle Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Embolization Particle Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Embolization Particle Sales by Application (2017-2022) & (K Units)
    Table 52. North America Embolization Particle Sales by Application (2023-2028) & (K Units)
    Table 53. North America Embolization Particle Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Embolization Particle Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Embolization Particle Sales by Country (2017-2022) & (K Units)
    Table 56. North America Embolization Particle Sales by Country (2023-2028) & (K Units)
    Table 57. North America Embolization Particle Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Embolization Particle Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Embolization Particle Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Embolization Particle Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Embolization Particle Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Embolization Particle Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Embolization Particle Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Embolization Particle Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Embolization Particle Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Embolization Particle Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Embolization Particle Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Embolization Particle Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Embolization Particle Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Embolization Particle Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Embolization Particle Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Embolization Particle Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Embolization Particle Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Embolization Particle Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Embolization Particle Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Embolization Particle Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Embolization Particle Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Embolization Particle Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Embolization Particle Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Embolization Particle Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Embolization Particle Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Embolization Particle Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Embolization Particle Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Embolization Particle Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Embolization Particle Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Embolization Particle Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Embolization Particle Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Embolization Particle Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Embolization Particle Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Embolization Particle Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Embolization Particle Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Embolization Particle Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Embolization Particle Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Embolization Particle Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Embolization Particle Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Embolization Particle Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Embolization Particle Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Embolization Particle Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Embolization Particle Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Embolization Particle Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Embolization Particle Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Embolization Particle Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Embolization Particle Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Embolization Particle Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Embolization Particle Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Embolization Particle Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Sirtex Medical Corporation Information
    Table 108. Sirtex Medical Description and Major Businesses
    Table 109. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Sirtex Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Sirtex Medical Recent Developments
    Table 112. Merit Medical Corporation Information
    Table 113. Merit Medical Description and Major Businesses
    Table 114. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Merit Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Merit Medical Recent Developments
    Table 117. Cook Medical Corporation Information
    Table 118. Cook Medical Description and Major Businesses
    Table 119. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Cook Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Cook Medical Recent Developments
    Table 122. BTG Medical Corporation Information
    Table 123. BTG Medical Description and Major Businesses
    Table 124. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. BTG Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. BTG Medical Recent Developments
    Table 127. Boston Scientific Corporation Corporation Information
    Table 128. Boston Scientific Corporation Description and Major Businesses
    Table 129. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Boston Scientific Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Boston Scientific Corporation Recent Developments
    Table 132. Terumo Corporation Corporation Information
    Table 133. Terumo Corporation Description and Major Businesses
    Table 134. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Terumo Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Terumo Corporation Recent Developments
    Table 137. HENGRUI Medical Corporation Information
    Table 138. HENGRUI Medical Description and Major Businesses
    Table 139. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. HENGRUI Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. HENGRUI Medical Recent Developments
    Table 142. INterface BIOmaterials B.V. Corporation Information
    Table 143. INterface BIOmaterials B.V. Description and Major Businesses
    Table 144. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. INterface BIOmaterials B.V. Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. INterface BIOmaterials B.V. Recent Developments
    Table 147. Alicon Corporation Information
    Table 148. Alicon Description and Major Businesses
    Table 149. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Alicon Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Alicon Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Embolization Particle Distributors List
    Table 155. Embolization Particle Customers List
    Table 156. Embolization Particle Market Trends
    Table 157. Embolization Particle Market Drivers
    Table 158. Embolization Particle Market Challenges
    Table 159. Embolization Particle Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Embolization Particle Product Picture
    Figure 3. Global Embolization Particle Market Share by Type in 2021 & 2028
    Figure 3. Microspheres Product Picture
    Figure 4. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
    Figure 5. Drug-eluting Beads (DEBs) Product Picture
    Figure 6. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
    Figure 7. Global Embolization Particle Market Share by Application in 2021 & 2028
    Figure 8. Uterine Fibroid Embolization
    Figure 9. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    Figure 10. Liver Tumor Embolization
    Figure 11. Trauma Embolization
    Figure 12. Others
    Figure 13. Embolization Particle Report Years Considered
    Figure 14. Global Embolization Particle Sales 2017-2028 (K Units)
    Figure 15. Global Embolization Particle Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Embolization Particle Revenue 2017-2028 (US$ Million)
    Figure 17. Global Embolization Particle Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Embolization Particle Sales Market Share by Region (2017-2022)
    Figure 19. Global Embolization Particle Sales Market Share by Region (2023-2028)
    Figure 20. North America Embolization Particle Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Embolization Particle Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Embolization Particle Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Embolization Particle Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Embolization Particle Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Embolization Particle Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Embolization Particle Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Embolization Particle Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Embolization Particle Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Embolization Particle Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Embolization Particle Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Embolization Particle in the World: Market Share by Embolization Particle Revenue in 2021
    Figure 32. Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Embolization Particle Sales Market Share by Type (2017-2028)
    Figure 34. Global Embolization Particle Revenue Market Share by Type (2017-2028)
    Figure 35. Global Embolization Particle Sales Market Share by Application (2017-2028)
    Figure 36. Global Embolization Particle Revenue Market Share by Application (2017-2028)
    Figure 37. North America Embolization Particle Sales Market Share by Type (2017-2028)
    Figure 38. North America Embolization Particle Revenue Market Share by Type (2017-2028)
    Figure 39. North America Embolization Particle Sales Market Share by Application (2017-2028)
    Figure 40. North America Embolization Particle Revenue Market Share by Application (2017-2028)
    Figure 41. North America Embolization Particle Sales Share by Country (2017-2028)
    Figure 42. North America Embolization Particle Revenue Share by Country (2017-2028)
    Figure 43. U.S. Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Embolization Particle Sales Market Share by Type (2017-2028)
    Figure 46. Europe Embolization Particle Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Embolization Particle Sales Market Share by Application (2017-2028)
    Figure 48. Europe Embolization Particle Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Embolization Particle Sales Share by Country (2017-2028)
    Figure 50. Europe Embolization Particle Revenue Share by Country (2017-2028)
    Figure 51. Germany Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 52. France Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Embolization Particle Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Embolization Particle Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Embolization Particle Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Embolization Particle Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Embolization Particle Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Embolization Particle Revenue Share by Region (2017-2028)
    Figure 62. China Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 65. India Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Embolization Particle Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Embolization Particle Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Embolization Particle Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Embolization Particle Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Embolization Particle Sales Share by Country (2017-2028)
    Figure 77. Latin America Embolization Particle Revenue Share by Country (2017-2028)
    Figure 78. Mexico Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Embolization Particle Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Embolization Particle Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Embolization Particle Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Embolization Particle Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Embolization Particle Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Embolization Particle Revenue Share by Country (2017-2028)
    Figure 87. Turkey Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Embolization Particle Revenue (2017-2028) & (US$ Million)
    Figure 90. Embolization Particle Value Chain
    Figure 91. Embolization Particle Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Frequently Asked Questions
Embolization Particle report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Embolization Particle report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Embolization Particle report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports